To co-administer erlotinib and PFOB (Perfluorooctyl bromide) against the EGFR overexpressed in NSCLC, anti-EGFR aptamer-conjugated chitosan-immobilized liposomes were constructed. This evidence concerns the gene EGFR and non-small cell lung carcinoma.